A phase 3 study of ultra long-acting cabotegravir for the prevention of HIV in adults
Latest Information Update: 06 Mar 2024
At a glance
- Drugs Cabotegravir (Primary)
- Indications HIV infections
- Focus Registrational; Therapeutic Use
Most Recent Events
- 06 Mar 2024 New trial record